Blum&Grob advises Luciole Medical Ltd. in financing round
Luciole Medical Ltd. has successfully completed a CHF 5.3 million financing round. Luciole is a medtech company with products for monitoring blood flow and brain oxygenation. The financing was led by SVC-Ltd. for Risk Capital for SMEs as lead investor. Further new investors were Blue Ocean Ventures, Investiere and b-to-v Partners S.à.r.l. as co-investors. Numerous existing shareholders such as the Zürcher Kantonalbank also participated in the financing round.
Blum&Grob (Gian Marchet Kasper and Michael Kuhn) advised Luciole as legal counsel.
To access Luciole’s press release, please follow this link.